Ropes & Gray advised Athyrium Capital in connection with the sale of Alcresta Therapeutics, which develops novel products that deliver enzymatic solutions to those living with rare diseases. The transaction closed on March 12 and was announced in a press release.
Athyrium is a specialized asset management company focused on investment opportunities in the global health care sector. Founded in 2008, the company advises funds with over $4.6 billion in committed capital. The Athyrium team has substantial investment experience across a wide range of asset classes including public equity, private equity, fixed income, royalties, and other structured securities.
The Ropes & Gray team was led by private capital transactions partner Taylor Hart and included senior attorney Graham Foster, tax partner Adam Greenwood, and employment partner Kyle Higley.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.